Publicaciones en las que colabora con JOSÉ LUIS GONZÁLEZ LARRIBA (30)

2015

  1. A 50-gene signature is a novel scoring system for tumor-infiltrating immune cells with strong correlation with clinical outcome of stage I/II non-small cell lung cancer

    Clinical and Translational Oncology, Vol. 17, Núm. 4, pp. 330-338

  2. New Challenges in Kidney Cancer Management: Integration of Surgery and Novel Therapies

    Current Treatment Options in Oncology, Vol. 16, Núm. 3

  3. Renal cell cancer metastases to esophagus and stomach successfully treated with radiotherapy and pazopanib

    Anti-Cancer Drugs, Vol. 26, Núm. 1, pp. 112-116

2013

  1. Erlotinib versus pemetrexed for pretreated non-squamous non-small cell lung cancer patients in clinical practice

    Oncology (Switzerland), Vol. 84, Núm. 5, pp. 255-264

2011

  1. Optimizing first-line treatment in non-small cell lung cancer with bevacizumab

    Cancer and Chemotherapy Reviews, Vol. 6, Núm. 1, pp. 28-36

2009

  1. Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer

    Journal of Thoracic Oncology, Vol. 4, Núm. 7, pp. 891-910

2006

  1. Cáncer de pulmón

    Tiempos médicos: revista de educación médica continuada, Núm. 631, pp. 11-22

2004

  1. Melanoma: Tratamiento de la enfermedad avanzada

    Revisiones en Cancer, Vol. 18, Núm. 5, pp. 268-275

2002

  1. Diagnóstico por PET de una recidiva única en un paciente con carcinoma epidermoide de pulmón estadio I previamente resecado

    Oncologia, Vol. 25, Núm. 6, pp. 59-63

  2. Pretreatment prognostic factors for survival in patients with advanced urothelial tumors treated in a phase I/II trial with paclitaxel, cisplatin, and gemcitabine

    Cancer, Vol. 95, Núm. 4, pp. 751-757

2001

  1. Cisplatin-5-fluorouracil-leucovorin (PFL) as neoadjuvant therapy in patients with locally advanced squamous cell carcinoma of the head and neck. Results after long term follow-up

    Clinical and Translational Oncology, Vol. 3, Núm. 6, pp. 300-305

2000

  1. Cost-effectiveness analysis of interferon as adjuvant therapy in high-risk melanoma patients in Spain

    European Journal of Cancer, Vol. 36, Núm. 18, pp. 2344-2352

  2. Encefalopatía aguda en pacientes en tratamiento con 5-fluorouracilo en infusión contínua: Presentación de un caso con evolución fatal

    Oncologia, Vol. 23, Núm. 7, pp. 51-55

  3. Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium

    Journal of Clinical Oncology, Vol. 18, Núm. 18, pp. 3247-3255

1994

  1. Aztreonam in association with piperacillin as an empirical antibiotic treatment in febrile granulocytopenic patients with solid tumors

    Oncology Reports, Vol. 1, Núm. 1, pp. 233-236

  2. ESTUDIO CON REPARTO ALEATORIO DE NAVELBINA FRENTE A NAVELBINA Y CISPLATINO FRENTE A VINDESINA Y CISPLATINO EN EL TRATAMIENTO DEL CARCINOMA PULMONAR NO MICROCELULAR INOPERABLE. RESULTADOS DE UN ESTUDIO MULTICENTRICO EUROPEO INCLUYENDO 612 PACIENTES

    Revista Clinica Espanola, Vol. 194, Núm. 11, pp. 953-959

  3. Neutropenic enteritis: A two-case report and literature review

    Oncology Reports, Vol. 1, Núm. 6, pp. 1211-1215

  4. Re: (treatment of advanced colorectal cancer with recombinant interferon alpha and fluorouracil: Activity in liver metastasis)

    Cancer Investigation, Vol. 12, Núm. 1, pp. 101-102

1993

  1. Ifosfamide in advanced epidermoid head and neck cancer

    Cancer Chemotherapy and Pharmacology, Vol. 31, Núm. 4, pp. 340-342

1991

  1. SINDROME DE LA VENA CAVA SUPERIOR EN EL CARCINOMA MICROCITICO DE PULMON: INCIDENCIA, RESPUESTA AL TRATAMIENTO E IMPORTANCIA PRONOSTICA

    Revista Clinica Espanola, Vol. 189, Núm. 6, pp. 268-271